MENU

News & Topics
Back Number

  • Information
    There is a concern that the infection will spread again due to the occurrence of mutant strain patients.
    Thus, the iCONM shall update the action guidelines for employees and shall strive for continuous prevention.
    Our staff and scientists are recommended to work at home and staggered commuting. We may also ask you to refrain from visiting or having interviews for safety reasons. We apologize for any inconvenience.
    In addition, for unavoidable reasons, if you need to enter the center, you are strictly asked to disinfect hands, wear a mask, and enter from the side entrance.
    Thank you for your understanding and cooperation.
  • Summary of transmission regarding mRNA vaccines and medicines
    Contents on mRNA vaccines or mRNA drugs transmitted by iCONM / COINS scientists in the media will be timely posted.
    Please note that iCONM is a research institute that belongs to Kawasaki Institute of Industrial Promotion, therefore we are not able to respond to inquiries regarding the management of specific companies or the judgment of stocks.

    ITAKA Keiji, Principal Research Scientist (Professor, Tokyo Medical and Dental University)
    UCHIDA Satoshi, Deputy Principal Research Scientist (Associate Professor, Kyoto Prefectural University of Medicine)
    • Answer anxicious voices about mRNA vaccine
      12/26 TBS "Marutto Saturday"
    • 4/13 An interview article about the effects of vaccines and side reactions was published in the Kyoto Shimbun.
    • 5/12 Appeared in "CAST".
  • NEW 5/10/2021
    【Activity Report】 May 10 (Mon.), COINS Seminar #58 was held at web.
    Speaker: Kanjiro MIYATA / Associate Professor / Department of Materials Engineering, Graduate School of Engineering The University of Tokyo / Kataoka・Kinoh Lab, iCONMI
    Title: ‟ Nanomedicines for oligonucleotide delivery”
  • 4/26/2021
    【Information】 We will hold the 2nd iCONM Public Lecture ~Cancer treatment and clinical trial we want to know correctly~ at Web.
    May 29, 2021 (Sat.) 14:00-16:00 (The web meeting room will be open at 13:45-)
    Holding method: ZOOM Webinar *web conferencing software. we will let you know URL by the day before only for participants.
    Language: Japanese
    Program overview:
    "Greeting" Kazunori KATAOKA, Director General, iCONM
    "What we want to know about brain surgery - Especially brain tumor -" Prof. Yoshihiro MURAGAKI Vice Director, Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
    "What is clinical trials? - How can we receive a best treatment? -" Prof. Noriyuki KATSUMATA, Medical Oncology, Musashi Kosugi Hospital, Nippon Medical School. Articles on this subject have been published in multiple media.
  • 4/12/2021
    【Activity Report】 April 12th (Mon.), We held the 6th iCONM x COINS Internal Communication Event at web.
  • 4/12/2021
    【Information】We will hold the COINS Seminar #58 at Web.
    May 10 (Mon.) 15:00-16:30 (The web meeting room will be open at 14:45-)
    Speaker:Ph.D. Kanjiro MIYATA / Associate Professor / Department of Materials Engineering, Graduate School of Engineering The University of Tokyo
    Title: "Nanomedicines for oligonucleotide delivery"
    Holding method: ZOOM Webinar *web conferencing software. we will let you know URL by the day before only for participants. *Registration is now closed.
  • 4/1/2021
    【Activity Report】 March 27 (Sat.), The 1st iCONM Public Lecture was held simultaneously at zoom and public viewing. Three-part lecture with the theme “What is nanomedicine?”
    Part 1:"Who is the drug carrier?"/ Kazunori KATAOKA, Director General/Laboratory Head
    Part 2:"What is the cause of illness?"/ Saed Abbasi, Research Scientist
    Part 3:"By the way, what about vaccines?"/ Satoshi UCHIDA, Deputy Principal Research Scientist
  • 4/1/2021
    【Information】 April 2021, the newsletter "NanoSky Vol.8-COINS's original innovation plastic that connects to future medical care""T-form" has been published.
  • 3/26/2021
    【Information】 On Friday, March 26, Dr. Kazunori Kataoka, Director General of iCONM gave a lecture at the symposium of NanoTech in Thailand.
  • 3/25/2021
    【Activity Report】 March 25 (Thu.), COINS Seminar #57 was held at web.
    Speaker: Keiji ITAKA / Professor, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University / Itaka Lab, iCONMI
    Title: ‟ mRNA therapeutics: from vaccine to regenerative medicine”
  • 3/17/2021
    【Information】 3/18 15: 30-16: 00 Shimazaki, who is in charge of communication, will appear at Kawasaki FM "Kawasaki Hot ☆ Studio" and will introduce the highlights of the public lecture scheduled to be held on 3/27. You can also enjoy it on Internet radio, so please access it from the Kawasaki FM website. Is the keyword an egg?
  • 3/10/2021
    【Information】We will hold the COINS Seminar #57 at Web.
    March 25 (Thu.) 16:30-18:00 (The web meeting room will be open at 16:15-)
    Speaker: M.D.,Ph.D. Keiji ITAKA /Professor, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University / Itaka Lab, iCONMI
    Title: ‟ mRNA therapeutics: from vaccine to regenerative medicine”
    Holding method: ZOOM Webinar *web conferencing software. we will let you know URL by the day before only for participants. *Registration is now closed.
  • 3/10/2021
    【Press seminar】 The research group of Deputy Principal Research Scientist Dr. Satoshi Uchida (Associate Professor, Kyoto Prefectural University of Medicine) at the Innovation Center of NanoMedicine reported that optimized nano-micelles can induce efficient genome editing in the mouse brain. A press seminar was held.
    This research result was published in "Journal of Controlled Release"
  • 3/8/2021
    【Activity Report】 March 8th (Mon.), We held the 5th iCONM x COINS Internal Communication Event at web.
  • 3/4/2021
    【Award】 COINS received the Japan Open Innovation Prize (JOIP) Selection Committee Special Award.

  • 3/2/2021
    【Press Release】 A research group consisting of Prof. Yutaka Kondo, Yoshihiko Tasaki, Graduate student (Division of Cancer Biology, Nagoya University Graduate School of Medicine) made a new therapeutic drug that the targeting of TUG1 by anti-TUG1 coupled with our new cancer-specific drug delivery system (TUG1-DDS). This was collaborative research with Nagoya City University, The University of Tokyo, Innovation Center of NanoMedicine, Japanese Foundation for Cancer Research.
    This research result was published in "Cancer Research"
  • iCONM Kids
  • 1 min tips for COINS
  • iCONM Email Magazine, Click here for registration

iCONM Brochure

iCONM pamphlet

  • COINS SDGs Video
  • COINS

  • Challenge Global Crisis! The potential of King SkyFront that stood out in COVID-19

  • Introduction of iCONM <MRS TV>
  • Kawasaki City Brand Message PR Video


  • KING SKYFRONT PR Video "Dream"

  • Inteview of Director General, iCONM
  • Japan Science and Technology Agency
  • Public Interest Incorporated Foundation Institute of Industry Promotion-Kawasaki
  • KING SKYFRONT
  • TONOMACHI LifeScience Cluster Division